Betül Susamis Unaran
Betül is the Chief Strategy and Digital Officer and Executive Board Member of Zur Rose Group, a role she assumed in 2019. She is focused on shaping the company’s strategy to be the leader across Europe for digital healthcare ecosystems, using data and digital to bring the best products and solutions to people’s lives to empower them to manage their health. Prior to joining the company, Betül was the Global Head of Digital Medicines for Novartis Pharma, where she was also a member of the Global Commercial Leadership Team and Global Digital Leadership Team.
She was responsible for reimagining medicine with data and digital for better lives and healthcare outcomes. Betül was also previously the Global Head of Digital for Ferring Pharmaceuticals and worked at senior level for McKinsey & Company in London and Geneva, and Procter & Gamble in Germany and Turkey. Betül is part of the Advisory Board of Arsenal Capital Partners, a leading private equity firm focusing on investments in specialty industrials and healthcare businesses.
In 2021 Betül joined the Board of Directors of Ypsomed, a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 35 years’ experience.
She holds a bachelor’s degree in industrial engineering from Bogazici University and an MBA from INSEAD.
Betül was listed in the 2022 Global Top CDO 100 by HotTopics.ht in partnership with Hewlett Packard Enterprise (January 2022) and named one of “20 amazing Women leading Europe’s tech revolution” by Mindquest (April 2021).